article thumbnail

Risking It All For a New Business Model at Family Physicians of St. Joe

Family Physicians of St. Joseph

Joseph, the family medicine practice is committed to providing exceptional, affordable, patient-centered primary care in SW Michigan without reliance on insurance companies for payment of services. In 2007, Dr. Mancini joined the practice, followed by Dr. Meadows in 2012, and Dr. Gendernalik in 2015. Family Physicians of St.

article thumbnail

MN Legislative Session 2025: Updates on Health Care Bills

Minnesota Academy of Family Physicians

Committees reviewed a range of legislation, including efforts to address workforce shortages, expand insurance coverage and improve school health services. The bill passed by a voice vote and was referred to the State and Local Government Committee. Read a summary of S.F. The bill supports a coordinated approach to services.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

4th Circuit En Banc Judgment Affirms District Court Decision in Best Price Stacking Case

FDA Law Blog

The 4th Circuit three-judge panel decision relied heavily on the Supreme Court’s decision in Safeco Insurance Co. 47 (2007), which addressed the intent standard under the Fair Credit Reporting Act. of America v. Burr , 551 U.S. The Supreme Court has sought the views of the Department of Justice on this issue.

article thumbnail

Ding Dong is the Skinny Label (Effectively) Dead?

FDA Law Blog

Teva case, that the statutory provisions governing patent infringement, specifically induced infringement, do not address carve-outs. Teva received tentative approval in June 2003 and launched in 2007 after a blocking patent expired. The catch is, as we have learned from the GSK v. Par also has filed similar litigation.

IT 52
article thumbnail

Court Strikes Down CMS’s Accumulator Adjustment Rule That Threatened Manufacturer Patient Savings Programs

FDA Law Blog

The court also denied the government’s cross-motion and refused to find that Chevron deference applied. Insurers argue that the savings programs cause patients and their physicians to favor brand drugs over generics or cheaper formulary alternatives. It is uncertain whether the government will appeal the District Court’s decision.